These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6203155)

  • 1. [Significance of prostaglandins in arterial thrombosis pathology: survey of an ongoing experience].
    Duvivier A; David JL
    Rev Med Liege; 1984 May; 39(9):354-61. PubMed ID: 6203155
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)].
    Szczeklik A; Głusko P; Gryglewski R; Szczeklik J; Kostka-Trabka E; Grodzińska L; Nizanowski R; Dembińska-Kieć A; Skawiński S; Bieroń K; Billewicz O; Telesz E
    Przegl Lek; 1980; 37(9):659-62. PubMed ID: 6106960
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin.
    Szczeklik A; Nizankowski R; Skawinski S; Szczeklik J; Gluszko P; Gryglewski RJ
    Lancet; 1979 May; 1(8126):1111-4. PubMed ID: 86835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iloprost in Prinzmetal's angina.
    De Caterina R; Pelosi G; Carpeggiani C; Bernini W; Giannessi D; Lazzerini G; L'Abbate A
    Am J Cardiol; 1986 Sep; 58(6):553-4. PubMed ID: 2428232
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological effects of iloprost (ZK 36 374), a stable prostacyclin analogue, in man.
    Ylitalo P; Kaukinen S; Seppäla E; Nurmi AK; Pessi T; Krais T; Vapaatalo H
    Biomed Biochim Acta; 1984; 43(8-9):S399-402. PubMed ID: 6083786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of prostacyclin (PGI2) on retinal arteries].
    Zygulska-Machowa H; Kostka-Trabkowa E; Nitoń A; Dembińska-Kieciowa A; Kedzior A; Basista M; Gryglewski RJ
    Klin Oczna; 1984 Apr; 86(4):149-51. PubMed ID: 6381868
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized, double-blind, crossover comparison of iloprost with dextran in patients with peripheral arterial occlusive disease.
    Ylitalo P; Kaukinen S; Reinikainen P; Salenius JP; Vapaatalo H
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):197-204. PubMed ID: 1694831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin in the therapy of peripheral arterial disease.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Szczeklik J; Skawiński S; Głuszko P
    Adv Prostaglandin Thromboxane Res; 1980; 7():687-9. PubMed ID: 6989195
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic effectiveness of prostaglandins (PGs) in peripheral vascular disease (PVD).
    Linet OI; Mohberg NR
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():307-10. PubMed ID: 2473609
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative effectiveness of drug preparations given by intraarterial regional infusion to patients with occlusion of the distal arterial bed].
    Silaev IuS; Avchenko MT; Gus'kov OI
    Klin Med (Mosk); 1984 Jun; 62(6):89-93. PubMed ID: 6471805
    [No Abstract]   [Full Text] [Related]  

  • 11. [Continuous intra-arterial infusions in obliterating diseases of the lower limbs].
    Chudakov MI; Vorotyntsev SF
    Khirurgiia (Mosk); 1974 May; (5):87-90. PubMed ID: 4457694
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective fibrinolytic response in atherosclerotic patients--effect of iloprost and its possible mechanism of action.
    Bertelé V; Mussoni L; del Rosso G; Pintucci G; Carriero MR; Merati MG; Libretti A; de Gaetano G
    Thromb Haemost; 1988 Oct; 60(2):141-4. PubMed ID: 2464198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet responses observed during and after infusions of the prostacyclin analog ZK 36 374.
    Yardumian DA; Mackie IJ; Bull H; Machin SJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():359-62. PubMed ID: 2408446
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of prostacyclin and its analogs in coronary vasculopathy].
    Lenzi S; Bugiardini R
    Ann Ital Med Int; 1986 Jun; 1(2):141-51. PubMed ID: 2484319
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
    Kurbangaleev SM; Savel'ev IuS
    Vestn Khir Im I I Grek; 1974 Oct; 113(10):68-71. PubMed ID: 4432347
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of stable prostacyclin analogue ZK 36 374 to treat severe lower limb ischaemia.
    Chiesa R; Vicari A; Mari G; Galimberti M; Di Carlo V; Pozza G
    Lancet; 1985 Jul; 2(8446):95-6. PubMed ID: 2409417
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostacyclin therapy in peripheral arterial disease.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Skawiński S; Głuszko P; Korbut R
    Thromb Res; 1980 Jul 1-15; 19(1-2):191-9. PubMed ID: 6108623
    [No Abstract]   [Full Text] [Related]  

  • 18. [Iloprost, a stable prostacyclin derivative, in stage 4 arterial occlusive disease. A placebo-controlled multicenter study].
    Diehm C; Abri O; Baitsch G; Bechara G; Beck K; Breddin HK; Brock FE; Clevert HD; Corovic D; Marshall M
    Dtsch Med Wochenschr; 1989 May; 114(20):783-8. PubMed ID: 2470569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [First time hope for endangiitis patients].
    Keil TU
    Zahnarztl Mitt; 1989 Nov; 79(21):2462-3. PubMed ID: 2484145
    [No Abstract]   [Full Text] [Related]  

  • 20. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
    Belch JJ; McKay A; McArdle B; Leiberman P; Pollock JG; Lowe GD; Forbes CD; Prentice CR
    Lancet; 1983 Feb; 1(8320):315-7. PubMed ID: 6130330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.